AstraZeneca vaccine’s chief investigator backs India’s 12-16 week Covishield dose gap – The Economic Times

Clipped from: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-vaccines-chief-investigator-backs-indias-12-16-week-covishield-dose-gap/articleshow/83640773.cmsSynopsis In an interview with The Wire, Professor Andrew Pollard said the immunization policy in Britain and India should not be compared because of

1 1,245 1,246 1,247 1,248 1,249 2,359